Maternal blood glucose levels determine the severity of diabetic embryopathy in mice with different expression of copper-zinc superoxide dismutase (CuZnSOD)

Toxicological Sciences

Volumn 105, Issue 1, 2008, Pages 166-172

  Zabihi, Sheller ^a   Wentzel, Parri ^a   Eriksson, Ulf J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alloxan; CuZnSOD; Diabetes in pregnancy; Knockout mice; Oxidative stress; Transgenic mice

Indexed keywords

ALLOXAN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; ISOPROSTANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETIC EMBRYOPATHY; DISEASE SEVERITY; EMBRYO; EMBRYOPATHY; FEMALE; FETUS OUTCOME; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; KNOCKOUT MOUSE; MATERNAL DIABETES MELLITUS; MOUSE; NONHUMAN; PLACENTA WEIGHT; PREGNANCY; PROTEIN EXPRESSION; TERATOGENICITY; TRANSGENIC MOUSE; WILD TYPE;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FETAL RESORPTION; FETAL WEIGHT; GENOTYPE; ISOPROSTANES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PREGNANCY; PREGNANCY IN DIABETICS; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 49249138073     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn101     Document Type: Article

References (46)

1. Aberg, A., Westbom, L., and Kallen, B. (2001). Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum. Dev. 61, 85-95.
2. Benedetto, M., Anzai, Y., and Gordon, J. (1991). Isolation and analysis of the mouse genomic sequence encoding Cu(2+)-Zn2+ superoxide dismutase. Gene 99, 191-195.
3. Brent, R. L., and Fawcett, L. B. (1998). Nutritional studies of the embryo during early organogenesis with normal embryos and embryos exhibiting yolk sac dysfunction. J. Pediatr. 132, 6-16.
4. Casson, I., Clarke, C., Howard, C., McKendrick, O., Pennycook, S., Pharoah, P., Platt, M., Stanisstreet, M., van Velszen, D., and Walkinshaw, S. (1997). Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ 315, 275-278.
5. Cederberg, J., and Eriksson, U. J. (1997). Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology 56 350-357.
6. Cederberg, J., Galli, J., Luthman, H., and Eriksson, U. J. (2000). Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes 49, 101-107.
7. Didion, S., Ryan, M., Didion, L., Fegan, P., Sigmund, C., and Faraci, F. (2002). Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 91, 938-944.
8. Dunn, J., Sheehan, H., and McLetchie, N. (1943). Necrosis of islets of Langerhans produced experimentally. Lancet 241, 484-487.
9. Epstein, C., Avraham, K., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C., and Groner, Y. (1987). Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 84 8044-8048.
10. Eriksson, R. S. M., Thunberg, L., and Eriksson, U. J. (1989a). Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats. Diabetes 38, 764-772.
11. Eriksson, U. J. (1988). Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37, 365-374.
12. Eriksson, U. J., Bone, A. J., Turnbull, D. M., and Baird, J. D. (1989b). Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: Effect on maternal metabolism and fetal outcome. Acta Endocrinol. 120, 800-810.
13. Eriksson, U. J., and Borg, L. A. H. (1991). Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34, 325-331.
14. Eriksson, U. J., and Borg, L. A. H. (1993). Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42, 411-419.
15. Gerber, R., Holemans, K., O'Brien-Coker, I., Mallet, A., van Bree, R., Van Assche, F., and Poston, L. (2000). Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: Evidence of lipid peroxidation. Am. J. Obstet. Gynecol. 183, 1035-1040.
16. Greene, M. F. (2001). Diabetic embryopathy 2001: Moving beyond the ''diabetic milieu. Teratology 63, 116-118.
17. Hagay, Z., Weiss, Y., Zusman, I., Peled-Kamar, M., Reece, E., Eriksson, U., and Groner, Y. (1995). Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am. J. Obstet. Gynecol. 173, 1036-1041.
18. Hawk, S., Uriu-Hare, J., Daston, G., Jankowski, M., Kwik-Uribe, C., Rucker, R., and Keen, C. (1998). Rat embryos cultured under copper-deficient conditions develop abnormally and are characterized by an impaired oxidant defense system. Teratology 57, 310-320.
19. Hsu, J., Visner, G., Burr, I., and Nick, H. (1992). Rat copper/zinc superoxide dismutase gene: Isolation, characterization, and species comparison. Biochem. Biophys. Res. Commun. 186, 936-943.
20. Kubisch, H., Wang, J., Bray, T., and Phillips, J. (1997). Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46, 1563-1566.
21. Kucera, J. (1971). Rate and type of congenital anomalies among offspring of diabetic women. J. Reprod. Med. 7, 73-82.
22. Levanon, D., Lieman-Hurwitz, J., Dafni, N., Wigderson, M., Sherman, L., Bernstein, Y., Laver-Rudich, Z., Danciger, E., Stein, O., and Groner, Y. (1985). Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J. 4, 77-84.
23. Lowry, O., Rosebrough, N., Farr, A., and Randall, R. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 265-275.
24. Matzuk, M., Dionne, L., Guo, Q., Kumar, T., and Lebovitz, R. (1998). Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 139, 4008-4011.
25. Mills, J. L., Baker, L., and Goldman, A. S. (1979). Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28, 292-293.
26. Moley, K., Chi, M., Knudson, C., Korsmeyer, S., and Mueckler, M. (1998). Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat. Med. 4, 1421-1424.
27. Morrow, J., Hill, K., Burk, R., Nammour, T., Badr, K., and Roberts, L.n. (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U. S. A. 87, 9383-9387.
28. Oberley, L. (1988). Free radicals and diabetes. Free Radic. Biol. Med. 113, 113-124.
29. Palmer, A., Thomas, C., Gopaul, N., Dhir, S., Anggard, E., Poston, L., and Tribe, R. (1999). Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 41, 148-156.
30. Pampfer, S., de Hertogh, R., Vanderheyden, I., Michiels, B., and Vercheval, M. (1990). Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39, 471-476.
31. Pampfer, S., Vanderheyden, I., McCracken, J., Vesela, J., and De Hertogh, R. (1997). Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development 124, 4827-4836.
32. Pinter, E., Reece, E. A., Leranth, C. S., Sanyal, M. K., Hobbins, J. C., Mahoney, M. J., and Naftolin, F. (1986). Yolk sac failure in embryopathy due to hyperglycemia: Ultrastructural analysis of yolk sac differentiation associated wilh embryopathy in rat conceptuses under hyperglycemic condition. Teratology 33, 73-84.
33. Rosen, D. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362.
34. Sadler, T. (1980). Effects of maternal diabetes on early embryogenesis: II. Hyperglycemia-induced exencephaly. Teratology 21, 349-356.
35. Sivan, E., Lee, Y., Wu, Y., and Reece, E. (1997). Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56, 343-349.
36. Styrud, J., Dahlstrom, V., and Eriksson, U. (1986). Induction of skeletal malformations in the offspring of rats fed a zinc deficient diet. Ups. J. Med. Sci. 91, 29-36.
37. Tiedge, M., Lortz, S., Drinkgern, J., and Lenzen, S. (1997). Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46, 1733-1742.
38. Uchigata, Y., Yamamoto, H., Kawamura, A., and Okamoto, H. (1982). Protection by superoxide dismutase, catalase, and poty(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 257, 6084-6088.
39. Weksler-Zangen, S., Yaffe, P., and Omoy, A. (2003). Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res. A Clin. Mol. Teratol. 67, 429-437.
40. Wentzel, P., and Eriksson, U. (2002). 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro. Tératology 66, 164-168.
41. Wentzel, P., and Eriksson, U. (2006). Ethanol-induced fetal dysmorphogenesis in the mouse is diminished by high antioxidative capacity of the mother. Toxicol. Sci. 92, 416-422.
42. Wentzel, P., Thunberg, L., and Eriksson, U. J. (1997). Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40, 7-14.
43. West, I. (2000). Radicals and oxidative stress in diabetes. Diabet. Med. 17, 171-180.
44. White, C., Avraham, K., Shanley, P., and Groner, Y. (1991). Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J. Clin. Invest. 87, 2162-2168.
45. Yang, S., Uriu-Adams, J., Keen, C., Rucker, R., and Lanoue, L. (2006). Effects of copper deficiency on mouse yolk sac vasculature and expression of angiogenic mediators. Birth Defects Rd. B Dev. Reprod. Toxicol. 77, 445-454.
46. Yarom, R., Sapoznikov, D., Havivi, Y., Avraham, K., Schickler, M., and Groner, Y. (1988). Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: A model for tongue pathology in Down's syndrome. J. Neurol. Sci. 88, 41-53.